Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

phenylacetyl-leucyl-aspartyl-phenylalanyl-prolineamide

Known as: PhAc-LDFP, phenylacetyl-leucyl-aspartyl-phenylalanyl-prolinamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Methane is a potent greenhouse gas, 25 times more efficient at trapping heat than carbon dioxide. Ruminant methane emissions… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2006
2006
Four new conformationally restricted analogues of a potent and selective neuronal nitric oxide synthase inhibitor, l… Expand
2004
2004
Cloned penicillin G acylase (PGA) from Escherichia coli ATCC 11105 was mutagenized in vivo using N-methyl-N′-nitrosoguanidine… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
Highly Cited
1999
Highly Cited
1999
Some antagonists of human growth hormone-releasing hormone (hGH-RH) synthesized previously were shown to inhibit in vivo… Expand
1998
1998
Based on our previous results, in conjunction with various structural considerations, 19 new analogs of the GHRH antagonist [PhAc… Expand